Chromatrap® reports on the excellent results achieved by customers using their 96 well high throughput plates for ultra-pure DNA purification.
Using proprietary filtration media that offer much higher loadings of active material, assay times of less than 5 minutes are routinely achievable. Customers report that using Chromatrap® DNA purification kit that DNA samples ranging from 50 bp up to 23 kb can be purified with up to 98% recovery.....
Horizon Discovery Group plc, the world leader in the application of gene editing technologies including molecular reference standards, announces the launch of its first HDx™ cfDNA (cell-free DNA) Reference Standard in Synthetic Plasma.
Since being pioneered by Horizon co-founder Professor Alberto Bardelli for the detection of KRAS mutations in serum to identify resistant populations to EGFR targeted therapy, liquid biopsy testing has emerged as one of the fastest growing areas in diagnostics, with cfDNA testing set to reach $9.0 billion by 2022....
Deben have supplied leading German instrument manufacturers, JPK Instruments, with a tensile stage to use in conjunction with the world-renowned NanoWizard® AFM platform.
Dr Torsten Mueller is a member of the development team with German nanoscience instrument makers, JPK Instruments. Dr Mueller and his colleagues are based in Berlin supporting a worldwide user network which is continuously testing JPK with requests for new capabilities for their life science and materials nanoscience systems....
Metrohm USA is pleased to announce the winner of its 2017 Young Chemist Award, Aldin Malkoc.
Aldin is completing his graduate work at Arizona State University where he works under the supervision of Professor Michael Caplan, Chair of the Biomedical Engineering Department, and Assistant Professor Jeffrey LaBelle. Aldin’s research focuses on cooperative, DNA-based molecular elements for electrochemical biosensors.....
Quo-Test point of care HbA1c analyzer readily meets key performance criteria for diabetes patient monitoring
EKF Diagnostics, the global in vitro diagnostics company, announces that in a newly published paper its Quo-Test® point-of-care (POC) hemoglobin A1c (HbA1c) analyzer has again been confirmed to meet International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) performance criteria....
Company Named Finalist for PACT Technology Company of the Year Award
ERT, a global data and technology company that minimizes risk and uncertainty in clinical trials, has announced it has been named a finalist for the Philadelphia Alliance for Capital and Technologies (PACT) Technology Company of the Year Award. ERT is one of only three companies nominated to receive this recognition....
Sartorius and EMBL join forces to offer advanced training and science education
Sartorius is now a member of the group of corporate EMBL partners aiming to connect industry to academia. Sartorius, a leading international laboratory and pharmaceutical equipment supplier, yesterday announced a partnership with EMBL, the European Molecular Biology Laboratory....
Portuguese Metrology Institute used Artel’s PCS Pipette Calibration System to report CMC for smallest liquid volume measurement on record
Artel, the leader in liquid handling quality assurance is pleased to announce that its technology was used in a project comparing the photometric and gravimetric methods for micropipette calibrations. Dr. Elsa Batista at the Portuguese National Metrology Institute (IPQ) led the study in the EURAMET Technical Committee for Flow, with participation of Artel’s metrology experts....
AMETEK Brookfield, the world standard for viscosity measurement and control, offers its Practical Course on Viscosity Measurements. This popular course was created to help AMETEK Brookfield Viscometer users comprehend the functionality of their instrument, solve the mysteries of fluid behavior and Rheology, and create successful and repeatable viscosity test methods for use in both R&D and QA/QC environments.....
JPK Instruments reports on how STM is being used to study surface plasmons in the Molecular Nanoscience Group at ISMO – Institut des Sciences Moléculaires d’Orsay – CNRS and the Université Paris-Sud.
One of the research goals of the Molecular Nanoscience Group at ISMO is to work towards circuits and devices in which surface plasmons (not electrons or photons) are used to transfer and manipulate information. However, why develop plasmonics when there are already solutions using electronics and photonics?....
Breakthrough advance offers the potential to defuse a ‘ticking timebomb’ for serious lung disease, including for over 1 billion smokers worldwide
The world’s biggest study into an individual’s genetic make-up and the risk of developing lung disease could allow scientists to more accurately ‘predict’ - based on genes and smoking - your chance of developing COPD, a deadly disease which is the third commonest cause of death in the world....
Unique technology portfolio enables design space characterization, effective translation to the large-scale and enhanced process analytics
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has developed an innovative and fully integrated technology platform to meet the requirements of today’s upstream bioprocessing. It will allow customers to adopt a Quality by Design (QbD) approach in which they build quality into their biological products by combining the power of high-throughput mini bioreactors with...
Chromatrap® has published a new application note that demonstrates how its unique solid state patented technology provides unrivalled sensitivity allowing users to perform ChIP assays using as few as 1000 cells per immunoprecipitation.
Usually large cell numbers are required for performing ChIP, which poses something of a challenge when dealing with limited starting material. The available techniques for tackling small amounts of sample, rare cell types or difficult cell types which provide low yield of chromatin are usually long and complex, and involve DNA amplification or the spiking of samples...
Second Crowdcube campaign for growth and international expansion
Following on from an extremely successful fund raising campaign in 2015, and a product launch in July 2016, ioLight is delighted to announce that its second crowd funding campaign is now live on the Crowdcube platform. The ioLight microscope is the first professional quality pocket digital microscope....
AMSBIO has published a new 25-page Neuroscience catalogue that details its extensive range of specific tools and reagents to enable researchers stay at the forefront of their field.
Cellular models are key tools that open the door to numerous neuroscience applications including neurodegeneration, neurogensis and developmental diseases. With the discovery that neural stem cells exist in the adult brain many researchers are now seeking to use these cells in in vitro studies....
Lonza will be showcasing its extensive portfolio of primary cells and 3D cell culture products designed to support cancer scientists at the AACR Annual Meeting 2017
As part of this, they will share new applications of the RAFT™ 3D Cell Culture System and primary cells, enabling researchers to more comprehensively devise and develop their cancer experiments. Lonza will present a poster ‘A 3-Dimensional RAFT™ Co-Culture as Advanced Model for Breast Cancer Drug Discovery’ demonstrating how the RAFT™ 3D Cell...
IDT expands its capacity for direct sales of genomic products in Asia-Pacific region
Integrated DNA Technologies (IDT), through its Singapore subsidiary, today completed the acquisition of the oligonucleotide manufacturing business of GeneWorks Pty Ltd. (GeneWorks) in Australia. This acquisition sees IDT expand its reach in the Asia-Pacific region, following its recent establishment of sales offices in Japan and Korea.....
Biological experiments are generating increasingly large and complex sets of data.
This has made it difficult to reproduce experiments at other research laboratories in order to confirm – or refute – the results. The difficulty lies not only in the complexity of the data, but also in the elaborate computer programmes and systems needed to analyse them. Scientists from the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of...
MRC researchers at the University of Leicester have shed light on critical gene network involved in neurological disease
“Studying the roles of genes such as ATF4 in human neurons could lead to tailored interventions that could one day prevent or delay the neuronal loss seen in Parkinson’s” – Dr Miguel Martins, MRC Toxicology Unit, University of Leicester. A genetic ‘switch’ has been discovered by MRC researchers at the University of Leicester which could help to prevent or delay the...
Once again, Systec GmbH, the leading manufacturer of autoclaves, including laboratory autoclaves, media preparators, and dispensing devices for liquid media and microbiological culture media, will be presenting the highlights of its comprehensive product range at ArabLab 2017.
The company's trusted line of laboratory autoclaves, suitable for almost any application, is based around the Systec H-Series, which includes large, standing horizontal autoclaves and pass-through / air lock autoclaves. The Systec Mediafill system, which is used to automatically fill and stack culture media in petri dishes but also tubes, is another focal point of the company's exhibition presentation...
Read MoreOne Million Tests a WeekMar 8, 2017
Analytik Jena Optimizes the Process for Ultra High throughput Screening
Analytik Jena has joined forces with Bruker Daltonics to accelerate lab processes: uHTS MALDI Sample Preparation in combination with label-free spectrometry guarantees reliable ultra high throughput screens in biopharmaceutical labs. Within the framework of their cooperation, the two companies have been able to build a bridge between matrix-assisted laser desorption/ionization (MALDI) and sample preparation....
Richmond Pharmacology, one of the UK’s leading early-phase contract research organisations, have opened their new research facility in London Bridge – at the site formerly known as the Guy’s Drug Research Unit.
The move is a significant boost to the UK’s efforts to continue to grow as a global hub for Life Sciences, an area of strategic importance outlined in the Government’s recent industrial strategy. With Richmond having already conducted over 300 studies in London since their establishment in 2001, the new facility will provide a central London base for Richmond Pharmacology’s further research utilising their enhanced capabilities in delivering world-leading, early-phase clinical trials....
Read More